Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic Read more about Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic171 views
Annual report: surveillance of adverse events following immunisation in Australia, 2008 Read more about Annual report: surveillance of adverse events following immunisation in Australia, 20087 views
Supplementary report: surveillance of adverse events following immunisation among children aged <7 years in Australia, 1 January to 30 June 2008 Read more about Supplementary report: surveillance of adverse events following immunisation among children aged 15 views
Annual report: surveillance of adverse events following immunisation in Australia, 2007 Read more about Annual report: surveillance of adverse events following immunisation in Australia, 200738 views
Anaphylaxis following quadrivalent human papillomavirus vaccination Read more about Anaphylaxis following quadrivalent human papillomavirus vaccination38 views
Monitoring vaccine safety: a critical component of every immunisation program [editorial] Read more about Monitoring vaccine safety: a critical component of every immunisation program [editorial] 49 views
Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2007 Read more about Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 20074 views
Annual report on surveillance of adverse events following immunisation in Australia, 2006 Read more about Annual report on surveillance of adverse events following immunisation in Australia, 200610 views
Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11–15 years: a randomised controlled trial Read more about Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11–15 years: a randomised controlled trial65 views
